edaravone has been researched along with Carditis in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, we tested the hypothesis that MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one; edaravone), a novel free radical scavenger, protects against acute experimental autoimmune myocarditis (EAM) in rats by the radical scavenging action associated with the suppression of cytotoxic myocardial injury." | 7.73 | MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats. ( Hattori, M; Kishimoto, C; Nimata, M; Okabe, TA; Shioji, K; Yuan, Z, 2005) |
| "In this study, we tested the hypothesis that MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one; edaravone), a novel free radical scavenger, protects against acute experimental autoimmune myocarditis (EAM) in rats by the radical scavenging action associated with the suppression of cytotoxic myocardial injury." | 3.73 | MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats. ( Hattori, M; Kishimoto, C; Nimata, M; Okabe, TA; Shioji, K; Yuan, Z, 2005) |
| "Edaravone-treated DCM rats showed better cardiac function compared with those of the vehicle-treated rats." | 1.38 | Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy. ( Arozal, W; Arumugam, S; Giridharan, VV; Harima, M; Kodama, M; Nagata, M; Nakamura, T; Palaniyandi, SS; Sari, FR; Soetikno, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimazaki, H | 1 |
| Watanabe, K | 3 |
| Veeraveedu, PT | 3 |
| Harima, M | 3 |
| Thandavarayan, RA | 3 |
| Arozal, W | 2 |
| Tachikawa, H | 1 |
| Kodama, M | 3 |
| Aizawa, Y | 1 |
| Arumugam, S | 2 |
| Nakamura, T | 1 |
| Sari, FR | 1 |
| Giridharan, VV | 2 |
| Soetikno, V | 2 |
| Palaniyandi, SS | 1 |
| Suzuki, K | 2 |
| Nagata, M | 2 |
| Tagaki, R | 1 |
| Nimata, M | 1 |
| Okabe, TA | 1 |
| Hattori, M | 1 |
| Yuan, Z | 1 |
| Shioji, K | 1 |
| Kishimoto, C | 1 |
4 other studies available for edaravone and Carditis
| Article | Year |
|---|---|
The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis.
Topics: Animals; Antioxidants; Antipyrine; Apoptosis; Autoimmune Diseases; Disease Models, Animal; Down-Regu | 2010 |
Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antipyrine; Apoptosis; Autoimmune Di | 2012 |
Involvement of AMPK and MAPK signaling during the progression of experimental autoimmune myocarditis in rats and its blockade using a novel antioxidant.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Antipyrine; Autoimmune Diseases; Disease Models, Anim | 2012 |
MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats.
Topics: Acute Disease; Animals; Antipyrine; Autoimmune Diseases; Cardiotonic Agents; Cytokines; Dose-Respons | 2005 |